| 05/22/2026 3:50 PM | Mineralys Therapeutics (1933414) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/19/2026 6:15 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 8:42 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 4:05 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/06/2026 4:15 PM | Mineralys Therapeutics (1933414) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/21/2026 5:59 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 3:17 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/15/2026 8:45 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 8:45 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 3:21 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 8:13 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MLYS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/13/2026 3:18 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 3:22 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/10/2026 3:24 PM | Mineralys Therapeutics (1933414) Filer | Form ARS | |
| 04/09/2026 3:24 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 7:47 AM | Mineralys Therapeutics (1933414) Filer | Form DEF 14A | |
| 04/08/2026 7:49 AM | Mineralys Therapeutics (1933414) Filer | Form DEFA14A | |
| 04/02/2026 5:53 PM | Karydas Daphne (1816952) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 5:54 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/31/2026 3:15 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:18 PM | Karydas Daphne (1816952) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/16/2026 4:20 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/13/2026 3:50 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 4:19 PM | Mineralys Therapeutics (1933414) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 3:13 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/10/2026 4:48 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 4:15 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/09/2026 3:36 PM | Mineralys Therapeutics (1933414) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 6:25 PM | Mineralys Therapeutics (1933414) Issuer Warren Eric (1916048) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/20/2026 6:46 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:46 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | DiRocco Derek (1792061) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | AKKARAJU SRINIVAS (1253170) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | Mineralys Therapeutics (1933414) Issuer Slingsby Brian Taylor (1963901) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | Karydas Daphne (1816952) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | Gold Alexander M (2026429) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | Mineralys Therapeutics (1933414) Issuer SBLENDORIO GLENN (1277478) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:47 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 6:49 PM | Kolchinsky Peter (1384859) Reporting Mineralys Therapeutics (1933414) Issuer RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 5:56 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 6:25 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
The SpaceX supplier that shipped 5 billion chips to Starlink (Ad) When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, supplier Broadcom gained 15,000%. The pattern is clear: suppliers often dwarf the headline stock.
One little-known company has shipped over 5 billion chips to SpaceX - a figure expected to reach 10 billion by 2027. SpaceX calls them 'instrumental to Starlink's success.' With the IPO expected in June, you can get the name, ticker, and a full year of tech research for just $19 - 85% off. Get the name and ticker before the SpaceX IPO arrives |
| 02/13/2026 3:30 PM | Catalys Pacific Fund, LP (1746274) Filed by Mineralys Therapeutics (1933414) Subject | Form SCHEDULE 13G/A | |
| 02/13/2026 8:21 AM | Mineralys Therapeutics (1933414) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/11/2026 5:58 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:20 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/05/2026 12:31 PM | Mineralys Therapeutics (1933414) Subject | Form SCHEDULE 13G | |
| 01/21/2026 11:30 AM | BlackRock, Inc. (2012383) Filed by Mineralys Therapeutics (1933414) Subject | Form SCHEDULE 13G | |
| 01/20/2026 7:33 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 3:26 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/15/2026 6:07 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 3:00 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/13/2026 7:43 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 7:43 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 7:43 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/13/2026 3:10 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 3:23 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 3:23 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 3:24 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/09/2026 3:23 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/06/2026 6:20 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 7:05 AM | Mineralys Therapeutics (1933414) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 4:18 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/24/2025 4:07 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/21/2025 5:07 PM | Catalys Pacific Fund, LP (1746274) Reporting Mineralys Therapeutics (1933414) Issuer Slingsby Brian Taylor (1963901) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 4:19 PM | Catalys Pacific Fund, LP (1746274) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 6:01 PM | Gold Alexander M (2026429) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 6:01 PM | Karydas Daphne (1816952) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 6:01 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 6:01 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 3:03 PM | Gold Alexander M (2026429) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/13/2025 3:04 PM | Karydas Daphne (1816952) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 3:28 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/12/2025 3:32 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2025 4:25 PM | Mineralys Therapeutics (1933414) Filer | Form S-3ASR | |
| 11/10/2025 4:11 PM | Mineralys Therapeutics (1933414) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/15/2025 6:04 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2025 6:04 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2025 6:04 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/15/2025 3:09 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/14/2025 9:09 AM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/14/2025 9:13 AM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/16/2025 5:54 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2025 3:12 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/08/2025 7:05 PM | Mineralys Therapeutics (1933414) Subject Samsara BioCapital, L.P. (1699737) Filed by | Form SCHEDULE 13D/A | |
| 09/08/2025 7:07 PM | AKKARAJU SRINIVAS (1253170) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2025 4:59 PM | Kolchinsky Peter (1384859) Reporting Mineralys Therapeutics (1933414) Issuer RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting Shah Rajeev M. (1619841) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2025 5:00 PM | Mineralys Therapeutics (1933414) Subject RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by | Form SCHEDULE 13D/A | |
| 09/02/2025 7:51 PM | Mineralys Therapeutics (1933414) Filer | Form S-3MEF | |
| 08/14/2025 5:02 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 4:21 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/12/2025 4:20 PM | Mineralys Therapeutics (1933414) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
June 12: $100 Turns Into $100,000? (Ad) The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast.
Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears. Click here to see how to get ahead of the SpaceX IPO |
| 07/30/2025 7:12 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/30/2025 4:30 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/30/2025 8:29 AM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/28/2025 4:38 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/15/2025 4:00 PM | Mineralys Therapeutics (1933414) Issuer Rodman David Malcom (1672659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 4:01 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2025 4:02 PM | Congleton Jon (1644975) Reporting Mineralys Therapeutics (1933414) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2025 3:23 PM | Mineralys Therapeutics (1933414) Subject Rodman David Malcom (1672659) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/11/2025 3:10 PM | Levy Adam Scott (1693134) Reporting Mineralys Therapeutics (1933414) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |